Psoriatic erythroderma and the efficacy of the IL-23 inhibitor guselkumab in clinical practice

I. S. Vladimirova; L. S. Kruglova

Medical alphabet
Medicinskij alfavit

ISSN 2078-5631 (Print)
ISSN 2949-2807 (Online)

User

eng | рус

Medical alphabet

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Vladimirova I.S., Kruglova L.S. Psoriatic erythroderma and the efficacy of the IL-23 inhibitor guselkumab in clinical practice. Medical alphabet. 2024;(25):90-98. (In Russ.) https://doi.org/10.33667/2078-5631-2024-25-90-98

Views PDF (Rus): 4

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2078-5631 (Print)
ISSN 2949-2807 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Petrikov Sergey S.

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

I. S. Vladimirova
Skin and Venereal Diseases Dispensary No. 10 – Clinic of Dermatology and Venereology; S.M. Kirov Military Medical Academy
Russian Federation

Irina S. Vladimirova - PhD Med, dermatovenerologist, Skin and Venereal Diseases Dispensary No. 10 – Clinic of Dermatology and Venereology; senior lecturer at Dept of Skin and Venereal Diseases, S.M. Kirov Military Medical Academy.

St. Petersburg

L. S. Kruglova
Central State Medical Academy of the Administrative Department of the President of Russia
Russian Federation

Larisa S. Kruglova - DM Sci (habil.), professor, head at Dept of Dermatovenereology and Cosmetology.

Moscow

Notifications

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Medical alphabet

For citations:

Cookies policy